Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received two suspension orders for drug licenses from the Drugs Control Administration. A store in Narsapur, Telangana had its license suspended for 2 days with a potential revenue loss of Rs 0.18 lakhs. A second store in Shimoga, Karnataka had its license suspended for 5 days with a potential revenue loss of Rs 4.85 lakhs. The total potential revenue impact across both stores is approximately Rs 5.03 lakhs. The suspensions are under Rule 65 of the Drugs and Cosmetics Act, 1940 and Rules, 1945.
Minor financial impact with combined potential revenue loss of Rs 5.03 lakhs. The suspension affects only 2 stores out of the company's network, with the Karnataka store accounting for the majority of the loss.